While all can lead to a profound increase in energy, they achieve this through distinctly different mechanisms
It binds GHS-R1a with high affinity but shows minimal activity at other receptor systems, including those mediating cortisol release (CRH/ACTH axis), prolactin release, or appetite stimulation pathways independent of GH signaling
Hence, new such applications of GLP-1 drugs are being studied, for Alzheimer's, polycystic ovary syndrome (PCOS), Non-alcoholic fatty liver disease (NAFLD), etc
Polycystic ovary syndrome creates insulin resistance that partially counteracts GLP-1 effects
Treatment begins with an initial consultation and lab work to ensure the therapy is right for you
Measurement of oxidized/reduced glutathione ratio. Methods Mol Biol